The Center’s Peter Caravan has been named Professor of Radiology at Harvard Medical School.
Caravan is Director of a multidisciplinary and translational molecular imaging group at the Center (the Caravan Lab) and co-director of the Institute for Innovation in Imaging (I3) at Massachusetts General Hospital. During his tenure in the Center, he has established himself as a world leader in the development of novel molecular probes and their application in a number of areas: among them, cardiovascular, pulmonary, renal and hepatic diseases, as well as cancers. His recent advances include a gadolinium-free MR contrast agent to improve the safety of contrast enhanced MRI as well as a fibrin-targeted PET radiotracer and a collagen-targeted PET radiotracer. The two PET radiotracers are currently under evaluation in six clinical trials.
In addition to his promotion, Caravan was recently recognized for his work with the Torsten Almén Award for Pioneering Research in Contrast Media, at the 2019 Contrast Media Research congress in Erice, Siciliy. Also, later this month, he will be honored with with the Thrall Mentoring Award from Massachusetts General Hospital.